FCN News / April 30, 2026 First Choice Neurology is proud to celebrate a remarkable achievement within its leadership team.

NextGen Jane, Inc. today announced results from a study showing that neurofilament light chain (NfL), a widely used marker of ...

Tapia, MD, PhD, discusses the results of the ADAPT OCULUS trial, which found promising results for treating patients with ...

The California-based biotech has hired Omeros and AbbVie alum Nadia Dac as its new chief commercial officer, where she will ...

Atogepant led to improvements and showed no new safety signals in patients with chronic and episodic migraine after 3 years ...

Haemonetics Corporation announced that Chris Simon, President and CEO, will participate in a fireside chat with investors at the Bank of America 2026 Healthcare Conference on Tuesday, May 12, 2026 at ...

The annual meeting of the American Academy of Neurology was held this year from April 18 to 22 in Chicago. Participants ...

Diakonos Oncology Corp., a clinical-stage biotechnology company developing a new generation of immunotherapies to treat challenging and aggressive cancers, today announced the presentation of new ...

Adjunctive cannabidiol improved multiple TSC-associated neuropsychiatric symptoms, including irritability, in a phase 3b/4 study described by investigators as the first to assess these outcomes.

Menstrual migraine symptoms are more severe and bothersome than symptoms for other migraines, according to a poster presented ...

Eating more fiber, especially soluble fiber, may significantly reduce the risk for dementia among older adults, results of a ...

India-born Yavagal honored for advancing mechanical thrombectomy and expanding equitable stroke care worldwide.